The Lancet Planetary Health:因全球变暖导致肠道感染死亡病例预计会增加!

2021-07-09 MedSci原创 MedSci原创

随着全球变暖步伐加快,科学家开始担心融化的冰盖会导致海平面持续升高,以及越来越多的极端天气。但是,还有另外一种威胁不得不要引起人们的重视。

随着全球变暖步伐加快,科学家开始担心融化的冰盖会导致海平面持续升高,以及越来越多的极端天气。但是,还有另外一种威胁不得不要引起人们的重视,那就是肠道病原体对人类的健康产生威胁。

pixabay

由于全球变暖,肠道感染导致的死亡率预计会增加。对与温度变化有关的肠道感染在早期全球预测报告,未来高温在低收入国家所产生的健康风险更高。在全球范围内,预计到 2030 年全球与温度相关的超额死亡人数将在 21000-68000 人之间,但到 2050 年将略微下降到 15000-49000 人的范围内。

然而,在全球范围内,尚未有研究探讨因环境温度而导致的特异性肠道病原染的死亡率。近日,发表在The Lancet Planetary Health杂志的一项研究预测了随着社会人口发展和气候变化,全球变暖而导致的不同肠道感染的死亡率。

在这项研究中,研究人员预测了10种肠道病原体(非伤寒沙门氏菌、志贺氏菌、弯曲杆菌、霍乱、肠致病性大肠杆菌、产肠毒素大肠杆菌、伤寒、轮状病毒、诺如病毒和隐孢子虫)的基线死亡率。然后,通过年度温度异常和病原体温度敏感性来估算全球变暖导致的死亡率。

研究结果发现,2080年到2095年间,保守估计全球因温度导致的肠道感染死亡的平均人数可能低至6599人,悲观估计或高达83 888人。预计因温度而导致的死亡大多来自撒哈拉以南非洲和南亚,包括志贺氏菌病、隐孢子虫病和伤寒。

全球气候模型-不同情景下肠道病原体感染死亡率

然而,归因于轮状病毒和诺如病毒性肠炎等病毒感染的死亡人数大幅减少,这导致拉丁美洲和加勒比地区以及东亚和太平洋地区归因于肠道感染的死亡率减少。

综上,在气候变暖和不利的社会人口条件下,由温度引起的死亡率可能会增加,志贺氏菌病、隐孢子虫病和伤寒所导致的肠道感染死亡的贡献最大。因此,限制全球变暖和社会人口发展政策可能有助于降低未来肠道感染的死亡率。

原始出处

Paul L C Chua, MSc .et al.Global projections of temperature-attributable mortality due to enteric infections: a modelling study.The Lancet Planetary Health.2021.DOI:https://doi.org/10.1016/S2542-5196(21)00152-2

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1831234, encodeId=5e3b1831234e9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Aug 07 11:22:20 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772137, encodeId=67a11e72137c9, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Sun Oct 03 14:22:20 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861451, encodeId=8c0c18614510b, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Apr 08 10:22:20 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734398, encodeId=98301e34398e9, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Jan 02 11:22:20 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459983, encodeId=26621459983b8, content=<a href='/topic/show?id=f1c78168032' target=_blank style='color:#2F92EE;'>#肠道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81680, encryptionId=f1c78168032, topicName=肠道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b16221893, createdName=medscijoin, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621912, encodeId=96ae162191219, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034385, encodeId=35d8103438533, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri Jul 09 17:22:20 CST 2021, time=2021-07-09, status=1, ipAttribution=)]
    2021-08-07 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1831234, encodeId=5e3b1831234e9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Aug 07 11:22:20 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772137, encodeId=67a11e72137c9, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Sun Oct 03 14:22:20 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861451, encodeId=8c0c18614510b, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Apr 08 10:22:20 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734398, encodeId=98301e34398e9, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Jan 02 11:22:20 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459983, encodeId=26621459983b8, content=<a href='/topic/show?id=f1c78168032' target=_blank style='color:#2F92EE;'>#肠道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81680, encryptionId=f1c78168032, topicName=肠道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b16221893, createdName=medscijoin, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621912, encodeId=96ae162191219, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034385, encodeId=35d8103438533, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri Jul 09 17:22:20 CST 2021, time=2021-07-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1831234, encodeId=5e3b1831234e9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Aug 07 11:22:20 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772137, encodeId=67a11e72137c9, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Sun Oct 03 14:22:20 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861451, encodeId=8c0c18614510b, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Apr 08 10:22:20 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734398, encodeId=98301e34398e9, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Jan 02 11:22:20 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459983, encodeId=26621459983b8, content=<a href='/topic/show?id=f1c78168032' target=_blank style='color:#2F92EE;'>#肠道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81680, encryptionId=f1c78168032, topicName=肠道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b16221893, createdName=medscijoin, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621912, encodeId=96ae162191219, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034385, encodeId=35d8103438533, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri Jul 09 17:22:20 CST 2021, time=2021-07-09, status=1, ipAttribution=)]
    2022-04-08 医者仁心
  4. [GetPortalCommentsPageByObjectIdResponse(id=1831234, encodeId=5e3b1831234e9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Aug 07 11:22:20 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772137, encodeId=67a11e72137c9, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Sun Oct 03 14:22:20 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861451, encodeId=8c0c18614510b, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Apr 08 10:22:20 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734398, encodeId=98301e34398e9, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Jan 02 11:22:20 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459983, encodeId=26621459983b8, content=<a href='/topic/show?id=f1c78168032' target=_blank style='color:#2F92EE;'>#肠道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81680, encryptionId=f1c78168032, topicName=肠道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b16221893, createdName=medscijoin, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621912, encodeId=96ae162191219, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034385, encodeId=35d8103438533, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri Jul 09 17:22:20 CST 2021, time=2021-07-09, status=1, ipAttribution=)]
    2022-01-02 canlab
  5. [GetPortalCommentsPageByObjectIdResponse(id=1831234, encodeId=5e3b1831234e9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Aug 07 11:22:20 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772137, encodeId=67a11e72137c9, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Sun Oct 03 14:22:20 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861451, encodeId=8c0c18614510b, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Apr 08 10:22:20 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734398, encodeId=98301e34398e9, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Jan 02 11:22:20 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459983, encodeId=26621459983b8, content=<a href='/topic/show?id=f1c78168032' target=_blank style='color:#2F92EE;'>#肠道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81680, encryptionId=f1c78168032, topicName=肠道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b16221893, createdName=medscijoin, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621912, encodeId=96ae162191219, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034385, encodeId=35d8103438533, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri Jul 09 17:22:20 CST 2021, time=2021-07-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1831234, encodeId=5e3b1831234e9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Aug 07 11:22:20 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772137, encodeId=67a11e72137c9, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Sun Oct 03 14:22:20 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861451, encodeId=8c0c18614510b, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Apr 08 10:22:20 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734398, encodeId=98301e34398e9, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Jan 02 11:22:20 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459983, encodeId=26621459983b8, content=<a href='/topic/show?id=f1c78168032' target=_blank style='color:#2F92EE;'>#肠道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81680, encryptionId=f1c78168032, topicName=肠道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b16221893, createdName=medscijoin, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621912, encodeId=96ae162191219, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034385, encodeId=35d8103438533, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri Jul 09 17:22:20 CST 2021, time=2021-07-09, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1831234, encodeId=5e3b1831234e9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Aug 07 11:22:20 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772137, encodeId=67a11e72137c9, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Sun Oct 03 14:22:20 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861451, encodeId=8c0c18614510b, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Apr 08 10:22:20 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734398, encodeId=98301e34398e9, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Sun Jan 02 11:22:20 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459983, encodeId=26621459983b8, content=<a href='/topic/show?id=f1c78168032' target=_blank style='color:#2F92EE;'>#肠道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81680, encryptionId=f1c78168032, topicName=肠道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b16221893, createdName=medscijoin, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621912, encodeId=96ae162191219, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jul 11 05:22:20 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034385, encodeId=35d8103438533, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri Jul 09 17:22:20 CST 2021, time=2021-07-09, status=1, ipAttribution=)]
    2021-07-09 goodbing

    顶刊就是不一样,质量很高,内容精彩!学到很多

    0

相关资讯

两千年来**温,真的会生这些病!

高温竟会导致呼吸系统、心血管系统疾病?还好要降温了...

Plos Med:全球变暖增加了与高温有关的心血管疾病的住院率

研究人员发现,男性比女性和69岁以下人群比70岁以上的人群的热效应增加更为严重。

Nature:温室效应将迎来全球范围内大面积降雨

  (图片摘自www.nature.com) 准备好下雨降临了吗?最近报道在nature climate change上的文章指出:气候变化已经引发了全球大面积的降雨与降雪,即使在干旱的地区。如果全球变暖效应仍在,这一趋势就会一直持续下去。 温室效应对全球范围内的降雨的影响到底如何一直以来没有确切的答案。但是最近的这项研究指出这一气候变化使得全球范围内的降雨量都发生了极大地提高。